コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 -regulating endopeptidase homolog), and Bsp (bone sialoprotein).
2 nimal role in mediating the PTH induction of bone sialoprotein.
3 (HA)-binding properties and bone tropism to bone sialoprotein.
4 as Col10, osterix, alkaline phosphatase, and bone sialoprotein.
5 ontain high levels of sialic acid similar to bone sialoprotein.
7 veral bone-associated proteins (osteopontin, bone sialoprotein, alkaline phosphatase, type I collagen
8 rkers of osteoblastic differentiation (i.e., bone sialoprotein and osteocalcin) in the preosteoblasts
10 osteocyte marker), while osteoblast markers, bone sialoprotein and osteopontin, remained unchanged.
11 ndicated that BMP-2 decreased mRNA levels of bone sialoprotein and type I collagen dose-dependently (
12 e increases in the expression of major bone (bone sialoprotein) and cartilage (type II collagen) matr
13 differentiation markers such as osteocalcin, bone sialoprotein, and dentin matrix protein 1 (DMP1) wa
14 ciated with significant reductions in Runx2, bone sialoprotein, and osteocalcin expression, parallele
16 N-linked glycoproteins) family of proteins, bone sialoprotein, and osteopontin, bound first to a cel
17 the osteogenic markers alkaline phosphatase, bone sialoprotein, and Runt-related transcription factor
18 total NCPs were separated into osteopontin-, bone sialoprotein-, and dentin matrix protein-1-enriched
21 ted transcription factor 2 at 7 days and for bone sialoprotein at days 7 and 10 as well as higher OPN
22 sized that the Staphylococcus aureus MSCRAMM bone sialoprotein-binding protein (Bbp) might recognize
23 gulase, exotoxin, Ser-Asp fibrinogen-binding bone sialoprotein-binding protein, fibrinogen and kerati
24 d osteonectin, whereas alkaline phosphatase, bone sialoprotein, bone Gla protein, and collagen II, al
28 DGF-BB or TGF-beta resulted in a decrease in bone sialoprotein (BSP) and osteocalcin (OCN) mRNAs whil
29 n situ hybridization, for gene expression of bone sialoprotein (BSP) and osteocalcin (OCN), and histo
30 Alendronate suppressed the expression of bone sialoprotein (BSP) and osteonectin in both femurs a
31 lecules associated with mineralized tissues, bone sialoprotein (BSP) and osteopontin (OPN), and a cel
33 inical correlation between the expression of bone sialoprotein (BSP) and skeletal metastasis of breas
34 nohistochemistry methods were used to detect bone sialoprotein (BSP) distribution in Hyp and WT mouse
35 study to determine the relationship between bone sialoprotein (BSP) expression and osteocalcin expre
36 ted growth and enhanced osteocalcin (OC) and bone sialoprotein (BSP) gene expression in human prostat
40 llular phosphoproteins osteopontin (OPN) and bone sialoprotein (BSP) have been implicated in biologic
41 linked glycoproteins), osteopontin (OPN) and bone sialoprotein (BSP) in the Galnt1-null mice relative
48 ssociated proteins, i.e., osteopontin (OPN), bone sialoprotein (BSP), alkaline phosphatase (ALP), ost
49 aining bone acidic glycoprotein-75 (BAG-75), bone sialoprotein (BSP), and alkaline phosphatase that a
50 runt-related transcription factor 2 (RunX2), bone sialoprotein (BSP), and osteocalcin (OCN) messenger
52 ING proteins: full-length osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein 1 (DMP1),
53 nsfer and expression of osteocalcin (OC) and bone sialoprotein (BSP), genes pivotal to bone matrix fo
54 ion of a mineralized tissue-specific marker, bone sialoprotein (BSP), indicating that epithelial prod
55 levels of mineral-associated genes including bone sialoprotein (BSP), OC, and osteopontin (OPN) in th
56 Proliferating cell nuclear antigen (PCNA), bone sialoprotein (BSP), osteocalcin (OCN), and tartrate
57 ed cementoblast population (OC/CM) expressed bone sialoprotein (BSP), osteopontin (OPN), and OC, mark
61 prove this hypothesis, we infected 5-day-old bone sialoprotein (BSP)/avian retroviral receptor gene (
62 ays for core binding factor alpha-1 [Cbfa1], bone sialoprotein [BSP], osteocalcin [OCN], and osteopon
63 s: bone marrow mesenchymal stem cell, BMMSC; bone sialoprotein, BSP; hydroxyapatite/tricalcium phosph
64 ly of integrin-binding phosphoglycoproteins (bone sialoprotein, BSP; osteopontin, OPN; and dentin mat
65 target genes, osteocalcin, osteopontin, and bone sialoprotein but did not significantly alter Runx2
66 and a significant decrease in expression of bone sialoprotein, characteristics of periodontal ligame
67 o OSE2 preceded increases in osteocalcin and bone sialoprotein expression and this increase in Osf2 b
68 , these results suggest that osteocalcin and bone sialoprotein expression is coordinated and regulate
69 study is to investigate how osteocalcin and bone sialoprotein expression is regulated in prostate ca
70 ed osteopontin and osteocalcin and decreased bone sialoprotein expression was detected within 7 days
71 conditioned medium-mediated osteocalcin and bone sialoprotein gene expression in prostate cancer cel
72 In differentiated MC4 cells, osteocalcin and bone sialoprotein gene expression were both down-regulat
73 evelopment (e.g. Col1a1, Postn/Osf2, and the bone sialoprotein gene or BSP), genes that are expressed
74 transcription factor in the osteocalcin and bone sialoprotein genes that cannot be resolved by tradi
75 ssion of osteoblast-specific osteocalcin and bone sialoprotein genes, alkaline phosphatase activity,
76 g the alkaline phosphatase, osteocalcin, and bone sialoprotein genes, and temporally associates with
77 trix phosphoproteins such as osteopontin and bone sialoprotein have yielded important biological info
78 t differentiation genes osterix (Sp7), Atf4, bone sialoprotein (Ibsp), and osteocalcin (Bglap) withou
79 tein (DSPP), dentin matrix protein 1 (DMP1), bone sialoprotein II (IBSP), and bone morphogenetic prot
80 line phosphatase/ALPL, osteopontin/SPP1, and bone sialoprotein II/IBSP) in a subset of the hMSC popul
81 ne phosphatase), Ocn (osteocalcin), and Bsp (bone sialoprotein) in response to recombinant PP and sta
86 at calcium deposition and gene expression of bone sialoprotein, lipoprotein lipase, and fatty acid bi
87 A1 and osteocalcin mRNA levels and increased bone sialoprotein mRNA, consistent with an inhibition of
88 -fold increase in the steady-state levels of bone sialoprotein mRNAs within primary cultures of embry
89 ophages in response to added native purified bone sialoprotein (nBSP) and its dephosphorylated form (
90 versus normal human valves for osteopontin, bone sialoprotein, osteocalcin, alkaline phosphatase, an
91 educed osterix-producing cells and increased bone sialoprotein, osteocalcin, and BMP-7 expression.
92 vealed increased mRNA levels of osteopontin, bone sialoprotein, osteocalcin, and Cbfa1 in the calcifi
94 ogenic markers such as Runx2, Osterix, DMP1, Bone sialoprotein, Osteocalcin, NFATc1, and Schnurri-2,
95 ng ligand N-linked glycoproteins (SIBLINGs): bone sialoprotein, osteopontin, and dentin matrix protei
96 g demonstrated that a sizeable proportion of bone sialoprotein particles were located within a 50-nm
97 tion revealed that (a) human osteocalcin and bone sialoprotein promoter activities in an androgen-ind
98 ediated stimulation of human osteocalcin and bone sialoprotein promoter activities occurs through inc
99 um was found to induce human osteocalcin and bone sialoprotein promoter activities via increased CRE/
101 of an osteoblast-specific element within the bone sialoprotein promoter and demonstrate its regulatio
102 ) Deletion analysis of human osteocalcin and bone sialoprotein promoter regions identified cyclic AMP
103 tronectin, type I collagen, osteopontin, and bone sialoprotein) showed any detectable effect on PG me
105 alkaline phosphatase, bone Gla protein, and bone sialoprotein, suggesting an osteogenic phenotype.
107 ble in both genotypes, and the expression of bone sialoprotein was similar in tumor-bearing bones of
109 tic protein (BMP)-2, BMP-7, osteopontin, and bone sialoprotein were evaluated in alveolar sockets.
110 bone proteins, osteopontin, osteonectin, and bone sialoprotein, were identified in the protein extrac
111 ion factor 2), osteocalcin, osteopontin, and bone sialoprotein, were reduced proportionate to the red
112 n the pro-adhesive molecules osteopontin and bone sialoprotein, which is in contrast to the high leve
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。